These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3442954)

  • 41. Pharmacokinetics of levosimendan in healthy volunteers and patients with congestive heart failure.
    Sandell EP; Hayha M; Antila S; Heikkinen P; Ottoila P; Lehtonen LA; Pentikainen PJ
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S57-62. PubMed ID: 8907132
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of congestive heart failure on quinidine pharmacokinetics.
    Crouthamel WG
    Am Heart J; 1975 Sep; 90(3):335-9. PubMed ID: 1163425
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison of serum and saliva paracetamol concentrations.
    Smith M; Whitehead E; O'Sullivan G; Reynolds F
    Br J Clin Pharmacol; 1991 May; 31(5):553-5. PubMed ID: 1888625
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of paracetamol metabolism in young adult and elderly males.
    Miners JO; Penhall R; Robson RA; Birkett DJ
    Eur J Clin Pharmacol; 1988; 35(2):157-60. PubMed ID: 3191934
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The disposition of paracetamol and the accumulation of its glucuronide and sulphate conjugates during multiple dosing in patients with chronic renal failure.
    Martin U; Temple RM; Winney RJ; Prescott LF
    Eur J Clin Pharmacol; 1991; 41(1):43-6. PubMed ID: 1782975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative pharmacokinetics of Panadol Extend and immediate-release paracetamol in a simulated overdose model.
    Tan C; Graudins A
    Emerg Med Australas; 2006 Aug; 18(4):398-403. PubMed ID: 16842311
    [TBL] [Abstract][Full Text] [Related]  

  • 47. THE EFFECT OF TOTAL AND PARTIAL NEPHRECTOMY ON THE PHARMACOKINETICS OF INTRAVENOUS PARACETAMOL IN HUMANS.
    Karbownik A; Polom W; Porazka J; Szalek E; Grabowski T; Wolc A; Matuszewski Marcin ; Grzesowiak E
    Acta Pol Pharm; 2017 May; 74(3):929-935. PubMed ID: 29513963
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assay of paracetamol and its metabolites in urine, plasma and saliva of children with chronic liver disease.
    al-Obaidy SS; Li Wan Po A; McKiernan PJ; Glasgow JF; Millership J
    J Pharm Biomed Anal; 1995 Jul; 13(8):1033-9. PubMed ID: 8580148
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The pharmacokinetics of midazolam in patients with congestive heart failure.
    Patel IH; Soni PP; Fukuda EK; Smith DF; Leier CV; Boudoulas H
    Br J Clin Pharmacol; 1990 May; 29(5):565-9. PubMed ID: 2350533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic doses of codeine have no effect on acetaminophen clearance or metabolism.
    Sonne J; Poulsen HE; Loft S; Døssing M; Vollmer-Larsen A; Simonsen K; Thyssen H; Lundstrøm K
    Eur J Clin Pharmacol; 1988; 35(1):109-11. PubMed ID: 3220092
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Paracetamol disposition in renal allograft recipients.
    Martin U; Temple RM; Venkat-Raman G; Prescott LF
    Eur J Clin Pharmacol; 2002 Feb; 57(12):853-6. PubMed ID: 11936703
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analgesic effect of i.v. paracetamol: possible ceiling effect of paracetamol in postoperative pain.
    Hahn TW; Mogensen T; Lund C; Jacobsen LS; Hjortsoe NC; Rasmussen SN; Rasmussen M
    Acta Anaesthesiol Scand; 2003 Feb; 47(2):138-45. PubMed ID: 12631041
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elimination of antipyrine from saliva as a measure of metabolism in man.
    Welch RM; DeAngelis RL; Wingfield M; Farmer TW
    Clin Pharmacol Ther; 1975 Sep; 18(3):249-58. PubMed ID: 1164815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk prediction of hepatotoxicity in paracetamol poisoning.
    Wong A; Graudins A
    Clin Toxicol (Phila); 2017 Sep; 55(8):879-892. PubMed ID: 28447858
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Theophylline elimination in congestive heart failure.
    Kuntz HD; Straub H; May B
    Klin Wochenschr; 1983 Nov; 61(21):1105-6. PubMed ID: 6645309
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Usefulness of salivary drug monitoring for detecting efflux transporter overexpression.
    Fagiolino P; Vázquez M; Maldonado C; Ruiz ME; Volonté MG; Orozco-Suárez S; Lazarowski A
    Curr Pharm Des; 2013; 19(38):6701-8. PubMed ID: 23530513
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hydralazine and furosemide kinetics.
    Nomura A; Yasuda H; Katoh K; Akimoto T; Miyazaki K; Arita T
    Clin Pharmacol Ther; 1982 Sep; 32(3):303-6. PubMed ID: 7105621
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of paracetamol after cardiac surgery.
    Hopkins CS; Underhill S; Booker PD
    Arch Dis Child; 1990 Sep; 65(9):971-6. PubMed ID: 2221970
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Paracetamol pharmacokinetics and metabolism in young women.
    Allegaert K; Peeters MY; Beleyn B; Smits A; Kulo A; van Calsteren K; Deprest J; de Hoon J; Knibbe CA
    BMC Anesthesiol; 2015 Nov; 15():163. PubMed ID: 26566962
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The pharmacokinetics of cotinine in plasma and saliva from non-smoking healthy volunteers.
    Curvall M; Elwin CE; Kazemi-Vala E; Warholm C; Enzell CR
    Eur J Clin Pharmacol; 1990; 38(3):281-7. PubMed ID: 2340848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.